6-K ·Filed Apr 16, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No immediate trading implications. Investors should await the actual dividend announcement and financial results, typically released after the board meeting.
Final — all horizons settled through T+60d
RDY ▼ -1.07% at T+60d
NEUTRAL call ✗ call lost -1.07% · α vs SPY -8.12% · entry $13.06 → $12.92
T+1d
+1.84%
call +1.84% · α +0.62%
$13.30
settled 6mo ago
T+5d
+3.98%
call +3.98% · α +3.00%
$13.58
settled 5mo ago
T+20d
-0.54%
call -0.54% · α -6.35%
$12.99
settled 5mo ago
T+60d
-1.07%
call -1.07% · α -8.12%
$12.92
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Dr. Reddy's Laboratories announced that its Board of Directors will consider recommending a final dividend for the fiscal year 2025-26. This is a routine disclosure ahead of an upcoming board meeting and contains no financial results or material changes to operations.
Key Facts
- Company: Dr. Reddy's Laboratories Ltd. (RDY)
- Filing Type: Form 6-K (foreign private issuer report)
- Event: Board meeting to consider final dividend for FY 2025-26
- Date of Filing: April 16, 2026
- No financial results, guidance, or material operational updates disclosed
Financial Impact
undisclosed amount
dividend
Risk Factors
- Dividend may be lower than expected or omitted
- No assurance that dividend will be approved
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000249 |
| Document: 0001575872-26-000249-index.html | 0001575872-26-000249 |
| Document: 0001575872-26-000249.txt | 0001575872-26-000249 |
51 reports for RDY
67% Hit rate best @ T+20▲ +23.28%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
Showing 10 of 51
US Market Status
Market Closed — Opens Mon (65h 27m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access